Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P3IZ
|
||||
| Former ID |
DIB007231
|
||||
| Drug Name |
E-2040
|
||||
| Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Terminated | [546598] | ||
| Company |
Eisai Co Ltd
|
||||
| Canonical SMILES |
c1(c(c(cc(N2CCN(CC2)CCO)c1)[C@H](F)CC)Cl)c1c(C#N)cccc1.<br />Cl
|
||||
| CAS Number |
CAS 172732-21-7
|
||||
| Target and Pathway | |||||
| Target(s) | 5-HT 2 receptor | Target Info | Modulator | [546599] | |
| D(3) dopamine receptor | Target Info | Modulator | [546599] | ||
| D(2) dopamine receptor | Target Info | Modulator | [546599] | ||
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Gap junction | |||||
| Serotonergic synapse | |||||
| Inflammatory mediator regulation of TRP channelshsa04080:Neuroactive ligand-receptor interaction | |||||
| Dopaminergic synapsehsa04015:Rap1 signaling pathway | |||||
| cAMP signaling pathway | |||||
| Dopaminergic synapse | |||||
| Parkinson's disease | |||||
| Cocaine addiction | |||||
| Alcoholism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.